BioProject: Browse

BioProject

Development of novel microbiome-driven therapies based on the meta-omics analysis (PRJDB19252)

The objective of this project is to evaluate and analyze the meta-omics-based gut microbiome of patients suffered from metabolic diseases including type 2 diabetes and inflammatory bowel disease, which the international human microbiome consortium has focused on. Based on the microbiome data, we aim to identify symbiotic microorganisms that either cause or prevent the metabolic diseases and investigate the underlying mechanisms for their actions which are ultimately used to develop therapeutics to manipulate the target diseases.

BioProject Information

Accession

KAP220130

Date and Organization


Submission Date	2022-04-15
Organization	Korea Research Institute of Bioscience and Biotechnology

Grant


Grant title	Development of novel microbiome-driven therapies based on the meta-omics analysis
Funding agency	한국연구재단

Publication and Patent

PubMed ID of publication		35346218
DOI of publication		10.1186/s12935-022-02554-6
Domestic patent number
International patent number

Associated Data

KRA

시퀀싱 원시 데이터

8

TOP